- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04382495
The Impact of COVID-19 Pandemic on Cancer Care
August 27, 2024 updated by: Aalaa Abdou, El Zaitoun Specialized Hospital
Impact of COVID-19 Pandemic on Cancer Care Provision: a Cross-sectional Study of Egyptian Patients' Perspectives and Concerns
The situation of COVID-19 pandemic creates many challenges for cancer patients and caregivers.
Some modifications in cancer management have been evolved from cancer societies and organizations to support oncology professionals as much as possible to deliver optimal care to their cancer patients in such exceptional circumstances, and to protect patients from infection with COVID-19 as much as possible.
Study Overview
Detailed Description
In oncology practice during this pandemic, many cancer patients still feeling uncertainty about their cancer management and treatment outcome .
The study is aiming to better understand the impact of the COVID-19 pandemic on cancer care from patients' and survivors' perspective.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 00202
- EgyBrit Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
the study survey will be distributed through social media to cancer patients and survivors in Egypt.
We plan to enroll as many participants as possible without limitation of the number although we hope to achieve at least 400 participants.
Description
Inclusion Criteria:
- cancer patients or survivors in Egypt.
Exclusion Criteria:
- No exclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patients' and survivors' perspective of their cancer care during COVID-19 pandemic
Time Frame: one month
|
measured by online survey to understand the impact of COVID-19 pandemic on cancer care
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Ahmed Abdelaziz, MD, Ain Shams University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2020
Primary Completion (Actual)
December 1, 2021
Study Completion (Actual)
January 30, 2022
Study Registration Dates
First Submitted
May 8, 2020
First Submitted That Met QC Criteria
May 8, 2020
First Posted (Actual)
May 11, 2020
Study Record Updates
Last Update Posted (Actual)
August 28, 2024
Last Update Submitted That Met QC Criteria
August 27, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cancer Care during Covid-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
email
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.